EPMap-System

EPMap-System was a Germany-based medical technology company focused on electrophysiology systems used in cardiac diagnosis and ablation procedures. Its core product, EPPerfect, was an integrated platform for intracardiac signal recording, stimulation, 3D navigation/mapping, and radiofrequency ablation workflow support. The company also offered related hardware, software, maintenance, safety checks, functional testing, and training services for electrophysiology laboratories. Based on available records, EPMap-System operated as a commercial-stage medtech company rather than a therapeutic drug developer. Corporate registry data indicate the company entered liquidation in 2023.